The Breast Cancer Now Generations Study is now using large-scale DNA sequencing to better understand genetic risk factors for breast cancer and other women’s health conditions. This could lead to improved, more personalised screening and prevention for all women—not just those with a family history. The research meets our rigorous security and privacy standards and is conducted in partnership with Regeneron, a global biomedical research company.

The Generations Study is celebrating its 20th anniversary. We want to take this opportunity to thank our participants for their participation and continued support of the study over the past 20 years. Here is a brief highlight of the amazing amount of data that has been collected, some of the important scientific findings and the key questions about breast cancer that we are currently asking.